| Brand | Active ingredient | Application holder | Expiry | Excl. |
|---|---|---|---|---|
| ABILIFY MYCITE KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 13 Jun | - |
| ABRAXANE | PACLITAXEL | BRISTOL-MYERS SQUIBB CO | 04 Mar | - |
| ABRAXANE | PACLITAXEL | BRISTOL-MYERS SQUIBB CO | 04 Sept | - |
| ACETADOTE | ACETYLCYSTEINE | APOTEX INC | 06 Apr | D-196 |
| ADZENYS ER | AMPHETAMINE | NEOS THERAPEUTICS INC | 28 Jun | - |
| ADZENYS XR-ODT | AMPHETAMINE | NEOS THERAPEUTICS | 28 Jun | - |
| AKYNZEO | FOSNETUPITANT CHLORIDE HYDROCHLORIDE; PALONOSETRON HYDROCHLORIDE | HELSINN HEALTHCARE SA | 23 May | - |
| ALECENSA | ALECTINIB HYDROCHLORIDE | HOFFMANN-LA ROCHE INC | 04 Mar | ODE-477 |
| ALIQOPA | COPANLISIB DIHYDROCHLORIDE | BAYER HEALTHCARE PHARMACEUTICALS INC | 29 Mar | - |
| ALKINDI SPRINKLE | HYDROCORTISONE | ETON PHARMACEUTICALS INC | 19 Nov | - |
| ALYFTREK | DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM | VERTEX PHARMACEUTICALS INC | 17 May | ODE-536 |
| AMVUTTRA | VUTRISIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 16 Nov | ODE-527 |
| APTIOM | ESLICARBAZEPINE ACETATE | SUMITOMO PHARMA AMERICA INC | 24 Aug | - |
| AQVESME | MITAPIVAT SULFATE | AGIOS PHARMACEUTICALS INC | 03 May | ODE-522 |
| AQVESME | MITAPIVAT SULFATE | AGIOS PHARMACEUTICALS INC | 26 Oct | ODE-522 |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 19 Mar | - |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 07 Nov | - |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 06 Dec | - |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | AXSOME THERAPEUTICS INC | 18 Jul | I-913 |
| AVYCAZ | AVIBACTAM SODIUM; CEFTAZIDIME | ABBVIE INC | 15 Jun | NPP |
| BAXDELA | DELAFLOXACIN MEGLUMINE | MELINTA SUBSIDIARY CORP | 01 May | GAIN |
| BELBUCA | BUPRENORPHINE HYDROCHLORIDE | BIODELIVERY SCIENCES INTERNATIONAL INC | 21 Dec | - |
| BIJUVA | ESTRADIOL; PROGESTERONE | MAYNE PHARMA LLC | 21 Nov | - |
| BIKTARVY | BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Aug | ODE-540 |
| BORTEZOMIB | BORTEZOMIB | FRESENIUS KABI USA LLC | 03 Nov | - |
| BRAFTOVI | ENCORAFENIB | ARRAY BIOPHARMA INC | 21 Nov | ODE-445 |
| BRENZAVVY | BEXAGLIFLOZIN | THERACOSBIO LLC | 14 May | NCE |
| BRIXADI | BUPRENORPHINE | BRAEBURN INC | 26 Jul | NP |
| BUNAVAIL | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | BIODELIVERY SCIENCES INTERNATIONAL INC | 20 Aug | - |
| CABENUVA KIT | CABOTEGRAVIR; RILPIVIRINE | VIIV HEALTHCARE CO | 13 Apr | NCE |
| CABOMETYX | CABOZANTINIB S-MALATE | EXELIXIS INC | 10 Feb | ODE-530 |
| CALDOLOR | IBUPROFEN | APOTEX INC | 16 Mar | NPP |
| CALQUENCE | ACALABRUTINIB | ASTRAZENECA UK LTD | 11 Jul | D-200 |
| CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | FRESENIUS KABI USA LLC | 21 Dec | - |
| CERDELGA | ELIGLUSTAT TARTRATE | GENZYME CORP | 05 Jun | - |
| CETYLEV | ACETYLCYSTEINE | ARBOR PHARMACEUTICALS LLC | 08 May | - |
| COMETRIQ | CABOZANTINIB S-MALATE | EXELIXIS INC | 10 Feb | - |
| CONTRAVE | BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 13 Jan | - |
| COPIKTRA | DUVELISIB | SECURA BIO INC | 10 Jan | - |
| COPIKTRA | DUVELISIB | SECURA BIO INC | 17 May | - |
| COPIKTRA | DUVELISIB | SECURA BIO INC | 24 Sept | - |
| COTEMPLA XR-ODT | METHYLPHENIDATE | NEOS THERAPEUTICS INC | 28 Jun | - |
| CYCLOSET | BROMOCRIPTINE MESYLATE | VEROSCIENCE LLC | 30 Apr | - |
| DAURISMO | GLASDEGIB MALEATE | PFIZER INC | 21 Nov | - |
| DAWNZERA (AUTOINJECTOR) | DONIDALORSEN SODIUM | IONIS PHARMACEUTICALS INC | 21 Oct | ODE-550 |
| DAYBUE | TROFINETIDE | ACADIA PHARMACEUTICALS INC | 27 Jan | PED |
| DAYBUE | TROFINETIDE | ACADIA PHARMACEUTICALS INC | 27 Jul | PED |
| DAYBUE STIX | TROFINETIDE | ACADIA PHARMACEUTICALS INC | 27 Jan | PED |
| DAYBUE STIX | TROFINETIDE | ACADIA PHARMACEUTICALS INC | 27 Jul | PED |
| DEFITELIO | DEFIBROTIDE SODIUM | JAZZ PHARMACEUTICALS INC | 22 Jun | - |
| DELSTRIGO | DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC | 30 Aug | - |
| DESCOVY | EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Aug | ODE-556 |
| DETECTNET | COPPER CU-64 DOTATATE | CURIUM US LLC | 23 Aug | ODE-317 |
| DEXILANT | DEXLANSOPRAZOLE | TAKEDA PHARMACEUTICALS USA INC | 05 Mar | - |
| DEXYCU KIT | DEXAMETHASONE | EYEPOINT PHARMACEUTICALS INC | 11 May | - |
| DILAUDID | HYDROMORPHONE HYDROCHLORIDE | FRESENIUS KABI USA LLC | 23 Apr | - |
| DILAUDID-HP | HYDROMORPHONE HYDROCHLORIDE | FRESENIUS KABI USA LLC | 23 Apr | - |
| DUVYZAT | GIVINOSTAT HYDROCHLORIDE | ITALFARMACO SPA | 03 Feb | ODE-473 |
| DUZALLO | ALLOPURINOL; LESINURAD | IRONWOOD PHARMACEUTICALS INC | 29 Feb | - |
| ELUCIREM | GADOPICLENOL | GUERBET | 25 May | NPP |
| EMBLAVEO | AVIBACTAM SODIUM; AZTREONAM | ABBVIE INC | 15 Jun | GAIN |
| EPANED KIT | ENALAPRIL MALEATE | AZURITY PHARMACEUTICALS INC | 06 Nov | - |
| EPCLUSA | SOFOSBUVIR; VELPATASVIR | GILEAD SCIENCES INC | 16 Nov | PED |
| EPSOLAY | BENZOYL PEROXIDE | MAYNE PHARMA LLC | 27 Nov | - |
| ERLEADA | APALUTAMIDE | JANSSEN BIOTECH INC | 14 Feb | - |
| EVOTAZ | ATAZANAVIR SULFATE; COBICISTAT | BRISTOL MYERS SQUIBB CO | 06 Oct | - |
| EVZIO | NALOXONE HYDROCHLORIDE | KALEO INC | 04 Feb | - |
| EVZIO (AUTOINJECTOR) | NALOXONE HYDROCHLORIDE | KALEO INC | 04 Feb | - |
| FETZIMA | LEVOMILNACIPRAN HYDROCHLORIDE | ABBVIE INC | 23 May | M-304 |
| FIRDAPSE | AMIFAMPRIDINE PHOSPHATE | CATALYST PHARMACEUTICALS INC | 29 Jun | ODE-553 |
| FIRMAGON | DEGARELIX ACETATE | FERRING PHARMACEUTICALS INC | 27 Apr | - |
| FLYRCADO | FLURPIRIDAZ F-18 | GE HEALTHCARE INC | 01 Nov | NCE |
| FRUZAQLA | FRUQUINTINIB | TAKEDA PHARMACEUTICALS USA INC | 23 Mar | NCE |
| GENVOYA | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Aug | - |
| GENVOYA | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 06 Oct | - |
| GILENYA | FINGOLIMOD HYDROCHLORIDE | NOVARTIS PHARMACEUTICALS CORP | 30 Mar | - |
| GILENYA | FINGOLIMOD HYDROCHLORIDE | NOVARTIS PHARMACEUTICALS CORP | 30 Sept | - |
| GONITRO | NITROGLYCERIN | G POHL BOSKAMP GMBH AND CO KG | 11 Mar | - |
| HARVONI | LEDIPASVIR; SOFOSBUVIR | GILEAD SCIENCES INC | 14 Sept | ODE* |
| HEPZATO | MELPHALAN HYDROCHLORIDE | DELCATH SYSTEMS INC | 07 Nov | ODE-438 |
| HEPZATO | MELPHALAN HYDROCHLORIDE | DELCATH SYSTEMS INC | 30 Dec | ODE-438 |
| IDVYNSO | DORAVIRINE; ISLATRAVIR | MERCK SHARP AND DOHME LLC | 30 Aug | NCE |
| ILEVRO | NEPAFENAC | HARROW EYE LLC | 31 Mar | - |
| IMCIVREE | SETMELANOTIDE ACETATE | RHYTHM PHARMACEUTICALS INC | 21 Aug | ODE-508 |
| IMVEXXY | ESTRADIOL | MAYNE PHARMA LLC | 21 Nov | - |
| INBRIJA | LEVODOPA | MERZ PHARMACEUTICALS LLC | 16 Nov | - |
| INLEXZO | GEMCITABINE HYDROCHLORIDE | JANSSEN BIOTECH INC | 15 Apr | NP |
| INREBIC | FEDRATINIB HYDROCHLORIDE | BRISTOL-MYERS SQUIBB CO | 04 Jun | ODE-259 |
| IONSYS | FENTANYL HYDROCHLORIDE | THE MEDICINES CO | 31 Mar | - |
| IONSYS | FENTANYL HYDROCHLORIDE | THE MEDICINES CO | 21 May | - |
| IONSYS | FENTANYL HYDROCHLORIDE | THE MEDICINES CO | 11 Jun | - |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC | 30 Mar | - |
| JASCAYD | NERANDOMILAST | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 23 Aug | ODE-546 |
| JOENJA | LENIOLISIB PHOSPHATE | PHARMING TECHNOLOGIES BV | 19 Feb | ODE-430 |
| JORNAY PM | METHYLPHENIDATE HYDROCHLORIDE | IRONSHORE PHARMACEUTICALS INC A WHOLLY OWNED SUB OF COLLEGIUM PHARMACEUTICAL INC | 23 Mar | - |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 09 May | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 09 May | PED |
| KORLYM | MIFEPRISTONE | CORCEPT THERAPEUTICS INC | 15 Nov | - |
| KORSUVA | DIFELIKEFALIN ACETATE | VIFOR (INTERNATIONAL) INC | 12 Nov | NCE |
| KUVAN | SAPROPTERIN DIHYDROCHLORIDE | BIOMARIN PHARMACEUTICAL INC | 01 Nov | - |
| KYBELLA | DEOXYCHOLIC ACID | ABBVIE INC | 17 Feb | - |
| LAZANDA | FENTANYL CITRATE | BTCP PHARMA LLC | 26 Jan | - |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | FRESENIUS KABI USA LLC | 29 Aug | - |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | FRESENIUS KABI USA LLC | 03 Oct | - |
| LINZESS | LINACLOTIDE | ABBVIE INC | 11 Feb | NPP |
| LINZESS | LINACLOTIDE | ABBVIE INC | 30 Apr | PED |
| LIVMARLI | MARALIXIBAT CHLORIDE | MIRUM PHARMACEUTICALS INC | 26 Oct | I-938 |
| LIVTENCITY | MARIBAVIR | TAKEDA PHARMACEUTICALS USA INC | 04 Jan | ODE-388 |
| LOKELMA | SODIUM ZIRCONIUM CYCLOSILICATE | ASTRAZENECA PHARMACEUTICALS LP | 10 Feb | - |
| LOKELMA | SODIUM ZIRCONIUM CYCLOSILICATE | ASTRAZENECA PHARMACEUTICALS LP | 19 Apr | - |
| LONHALA MAGNAIR KIT | GLYCOPYRROLATE | SUMITOMO PHARMA AMERICA INC | 01 Sept | - |
| LYBALVI | OLANZAPINE; SAMIDORPHAN L-MALATE | ALKERMES INC | 13 Feb | NCE |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 19 Jan | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 18 May | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 19 Jul | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 18 Nov | PED |
| MAYZENT | SIPONIMOD | NOVARTIS PHARMACEUTICALS CORP | 05 Jan | - |
| MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | NOVARTIS PHARMACEUTICALS CORP | 28 Jan | PED |
| MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | NOVARTIS PHARMACEUTICALS CORP | 28 Jul | PED |
| MINOCIN | MINOCYCLINE HYDROCHLORIDE | REMPEX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF MELINTA THERAPEUTICS LLC | 16 Oct | - |
| MIUDELLA | COPPER | SEBELA WOMENS HEALTH INC | 14 Aug | NP |
| MODEYSO | DORDAVIPRONE HYDROCHLORIDE | CHIMERIX INC | 30 Apr | ODE-547 |
| MOVANTIK | NALOXEGOL OXALATE | AVERITAS PHARMA INC | 02 Apr | - |
| NEOPROFEN | IBUPROFEN LYSINE | RECORDATI RARE DISEASES INC | 02 Mar | - |
| NETSPOT | GALLIUM DOTATATE GA-68 | NOVARTIS PHARMACEUTICALS CORP | 10 Aug | - |
| NEUPRO | ROTIGOTINE | UCB INC | 01 Mar | - |
| NEURACEQ | FLORBETABEN F-18 | LANTHEUS BIOSCIENCES LTD | 14 Jul | - |
| NUVESSA | METRONIDAZOLE | ALEMBIC THERAPEUTICS LLC | 28 Jun | - |
| ODEFSEY | EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Aug | - |
| OFIRMEV | ACETAMINOPHEN | MALLINCKRODT HOSP PRODUCTS IP LTD | 11 Mar | - |
| OLINVYK | OLICERIDINE | TREVENA INC | 23 Mar | - |
| OLUMIANT | BARICITINIB | ELI LILLY AND CO | 31 May | - |
| OLUMIANT | BARICITINIB | ELI LILLY AND CO | 30 Nov | - |
| ONGENTYS | OPICAPONE | AMNEAL PHARMACEUTICALS LLC | 11 Jan | - |
| ONGENTYS | OPICAPONE | AMNEAL PHARMACEUTICALS LLC | 12 Dec | - |
| ONPATTRO | PATISIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 10 Aug | M-270 |
| OXBRYTA | VOXELOTOR | GLOBAL BLOOD THERAPEUTICS INC | 28 Dec | ODE-394 |
| PATADAY ONCE DAILY RELIEF | OLOPATADINE HYDROCHLORIDE | ALCON LABORATORIES INC | 19 May | - |
| PIFELTRO | DORAVIRINE | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC | 30 Aug | - |
| PLENVU | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | SALIX PHARMACEUTICALS INC | 09 Mar | - |
| PLENVU | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | SALIX PHARMACEUTICALS INC | 25 Mar | - |
| PLENVU | ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE | SALIX PHARMACEUTICALS INC | 11 Aug | - |
| PONVORY | PONESIMOD | VANDA PHARMACEUTICALS INC | 06 May | NCE |
| PRECEDEX | DEXMEDETOMIDINE HYDROCHLORIDE | HOSPIRA INC | 04 Jan | - |
| PRECEDEX | DEXMEDETOMIDINE HYDROCHLORIDE | HOSPIRA INC | 04 Jul | - |
| PREZCOBIX | COBICISTAT; DARUNAVIR ETHANOLATE | JANSSEN PRODUCTS LP | 06 Oct | - |
| PROLENSA | BROMFENAC SODIUM | BAUSCH AND LOMB INC | 19 Nov | - |
| PYRUKYND | MITAPIVAT SULFATE | AGIOS PHARMACEUTICALS INC | 03 May | ODE-392 |
| PYRUKYND | MITAPIVAT SULFATE | AGIOS PHARMACEUTICALS INC | 26 Oct | ODE-392 |
| QINLOCK | RIPRETINIB | DECIPHERA PHARMACEUTICALS LLC | 07 Jun | ODE-298 |
| REXULTI | BREXPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 12 Oct | M-315 |
| REZZAYO | REZAFUNGIN ACETATE | MUNDIPHARMA GMBH | 02 Mar | GAIN |
| RIVIVE | NALOXONE HYDROCHLORIDE | HARM REDUCTION THERAPEUTICS INC | 11 May | - |
| ROZLYTREK | ENTRECTINIB | GENENTECH INC | 10 Mar | ODE-448 |
| RYKINDO | RISPERIDONE | SHANDONG LUYE PHARMACEUTICAL CO LTD | 10 Apr | - |
| SEYSARA | SARECYCLINE HYDROCHLORIDE | ALMIRALL LLC | 03 Jan | - |
| SINUVA | MOMETASONE FUROATE | INTERSECT ENT INC | 08 Feb | - |
| STIVARGA | REGORAFENIB | BAYER HEALTHCARE PHARMACEUTICALS INC | 09 Jul | - |
| STRIBILD | COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | GILEAD SCIENCES INC | 06 Oct | - |
| SUBLOCADE | BUPRENORPHINE | INDIVIOR INC | 06 Jan | M-314 |
| SYMTUZA | COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | JANSSEN PRODUCTS LP | 15 Aug | - |
| SYMTUZA | COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | JANSSEN PRODUCTS LP | 06 Oct | - |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 07 Mar | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 07 Sept | PED |
| TABRECTA | CAPMATINIB HYDROCHLORIDE | NOVARTIS PHARMACEUTICAL CORP | 19 Nov | ODE-291 |
| TAGRISSO | OSIMERTINIB MESYLATE | ASTRAZENECA PHARMACEUTICALS LP | 25 Jul | ODE-337 |
| TAGRISSO | OSIMERTINIB MESYLATE | ASTRAZENECA PHARMACEUTICALS LP | 08 Aug | ODE-337 |
| TASIGNA | NILOTINIB HYDROCHLORIDE | NOVARTIS PHARMACEUTICALS CORP | 07 Apr | PED |
| TASIGNA | NILOTINIB HYDROCHLORIDE | NOVARTIS PHARMACEUTICALS CORP | 07 Oct | PED |
| TAUVID | FLORTAUCIPIR F-18 | AVID RADIOPHARMACEUTICALS INC | 26 May | - |
| TAVALISSE | FOSTAMATINIB DISODIUM | RIGEL PHARMACEUTICALS INC | 27 Jul | - |
| TECHNIVIE | OMBITASVIR; PARITAPREVIR; RITONAVIR | ABBVIE INC | 13 Apr | - |
| TORISEL | TEMSIROLIMUS | PF PRISM CV | 10 May | - |
| TORISEL | TEMSIROLIMUS | PF PRISM CV | 10 Nov | - |
| TPOXX | TECOVIRIMAT | SIGA TECHNOLOGIES INC | 08 Aug | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 07 Mar | - |
| TRINTELLIX | VORTIOXETINE HYDROBROMIDE | TAKEDA PHARMACEUTICALS USA INC | 21 Mar | PED |
| TRINTELLIX | VORTIOXETINE HYDROBROMIDE | TAKEDA PHARMACEUTICALS USA INC | 21 Sept | PED |
| TRUDHESA | DIHYDROERGOTAMINE MESYLATE | IMPEL PHARMACEUTICALS LLC | 05 Sept | - |
| TRUDHESA | DIHYDROERGOTAMINE MESYLATE | IMPEL PHARMACEUTICALS LLC | 25 Dec | - |
| TRULANCE | PLECANATIDE | SALIX PHARMACEUTICALS INC | 01 Mar | - |
| TRULANCE | PLECANATIDE | SALIX PHARMACEUTICALS INC | 20 Aug | - |
| TRYNGOLZA (AUTOINJECTOR) | OLEZARSEN SODIUM | IONIS PHARMACEUTICALS INC | 27 Apr | ODE-515 |
| TUKYSA | TUCATINIB | SEAGEN INC | 12 Oct | ODE-422 |
| TUXARIN ER | CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE | MAINPOINTE PHARMACEUTICALS LLC | 03 Jan | - |
| TWYNEO | BENZOYL PEROXIDE; TRETINOIN | MAYNE PHARMA LLC | 29 Jun | - |
| TYBOST | COBICISTAT | GILEAD SCIENCES INC | 06 Oct | NPP |
| UBRELVY | UBROGEPANT | ABBVIE INC | 19 Jul | - |
| VALTOCO | DIAZEPAM | NEURELIS INC | 13 Jun | NPP |
| VALTOCO | DIAZEPAM | NEURELIS INC | 16 Oct | NPP |
| VANRAFIA | ATRASENTAN HYDROCHLORIDE | NOVARTIS PHARMACEUTICALS CORP | 18 Feb | NCE |
| VARITHENA | POLIDOCANOL | BOSTON SCIENTIFIC CORP | 12 May | - |
| VARUBI | ROLAPITANT HYDROCHLORIDE | TERSERA THERAPEUTICS LLC | 14 Jul | - |
| VAZALORE | ASPIRIN | PLX PHARMA INC | 29 Sept | - |
| VEKLURY | REMDESIVIR | GILEAD SCIENCES INC | 08 Jun | PED |
| VEKLURY | REMDESIVIR | GILEAD SCIENCES INC | 18 Nov | PED |
| VEMLIDY | TENOFOVIR ALAFENAMIDE FUMARATE | GILEAD SCIENCES INC | 15 Aug | NPP |
| VENCLEXTA | VENETOCLAX | ABBVIE INC | 29 Jan | ODE-239 |
| VENCLEXTA | VENETOCLAX | ABBVIE INC | 23 May | ODE-239 |
| VERQUVO | VERICIGUAT | MERCK SHARP AND DOHME LLC | 26 Nov | D-198 |
| VIEKIRA PAK (COPACKAGED) | DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR | ABBVIE INC | 13 Apr | - |
| VIEKIRA PAK (COPACKAGED) | DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR | ABBVIE INC | 04 Sept | - |
| VIEKIRA XR | DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR | ABBVIE INC | 13 Apr | - |
| VIEKIRA XR | DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR | ABBVIE INC | 17 May | - |
| VIEKIRA XR | DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR | ABBVIE INC | 04 Sept | - |
| VIZIMPRO | DACOMITINIB | PFIZER INC | 27 Sept | - |
| VOSEVI | SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR | GILEAD SCIENCES INC | 16 Nov | - |
| VYXEOS | CYTARABINE; DAUNORUBICIN | JAZZ PHARMACEUTICALS THERAPEUTICS INC | 15 Oct | PED |
| XARTEMIS XR | ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | MALLINCKRODT INC | 16 May | - |
| XCOPRI | CENOBAMATE | SK LIFE SCIENCE INC | 30 Oct | - |
| XEPI | OZENOXACIN | LNHC INC | 29 Jan | - |
| XERAVA | ERAVACYCLINE DIHYDROCHLORIDE | TETRAPHASE PHARMACEUTICALS INC | 27 Aug | GAIN |
| XOFLUZA | BALOXAVIR MARBOXIL | GENENTECH INC | 24 Oct | M-187 |
| XOSPATA | GILTERITINIB FUMARATE | ASTELLAS PHARMA US INC | 28 Nov | - |
| XPOVIO | SELINEXOR | KARYOPHARM THERAPEUTICS INC | 26 Jul | ODE* |
| ZAYNICH | CEFEPIME HYDROCHLORIDE; ZIDEBACTAM | WOCKHARDT BIO AG | 24 Aug | GAIN |
| ZECUITY | SUMATRIPTAN SUCCINATE | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC | 08 Oct | - |
| ZELBORAF | VEMURAFENIB | HOFFMANN LA ROCHE INC | 06 Jun | - |
| ZELSUVMI | BERDAZIMER SODIUM | LNHC INC | 03 Jul | NCE |
| ZEMDRI | PLAZOMICIN SULFATE | CIPLA USA INC | 25 Jun | GAIN |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 07 Sept | PED |
| ZERVIATE | CETIRIZINE HYDROCHLORIDE | HARROW EYE LLC | 09 Jul | - |
| ZOLPIMIST | ZOLPIDEM TARTRATE | AYTU BIOSCIENCE INC | 07 Aug | - |
| ZUBSOLV | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | EDENBRIDGE PHARMACEUTICALS LLC DBA DEXCEL PHARMA USA | 18 Sept | - |
| ZURAMPIC | LESINURAD | IRONWOOD PHARMACEUTICALS INC | 29 Feb | - |
| ZYKADIA | CERITINIB | NOVARTIS PHARMACEUTICALS CORP | 18 Jan | - |
| ZYKADIA | CERITINIB | NOVARTIS PHARMACEUTICALS CORP | 02 Feb | - |
Provenance
Source: FDA Orange Book patent and exclusivity files. Rows carrying an exclusivity code have a separate regulatory exclusivity that can outlast the patent shown. Patent expiry alone does not determine when a generic can launch: paediatric extensions, 30-month stays and settlement agreements frequently move the effective date. Delisted patents are excluded.